News - 15 Apr 2007
Gleevec, a pill developed in conjunction with the Oregon Health & Science University Cancer Institute is again showing excellent results in preventing a cancer recurrence.
News - 7 Jun 2006
In what is great news for those suffering from chronic myeloid leukaemia (CML), the drug Glivec looks like being one of the biggest breakthroughs in cancer therapy for a years.
News - 10 Feb 2011
The American Dental Association today commended Reps. Michael Burgess (R-Tex.) and Edolphus Towns (D-N.Y.) for introducing the Dental Emergency Responder Act (H.R. 570), a bill that would bolster the...
News - 15 Jan 2009
New research published in the January issue of the Journal of the American College of Surgeons shows that laparoscopic removal of gastrointestinal stromal tumors (GISTs) is safe and effective, with a...
News - 23 Sep 2004
Imatinib is approved worldwide for use in GIST, tumours which do not respond to conventional chemotherapy, which have a prevalence of around 20 per 100,000 population.
News - 19 Oct 2009
Two Kansas State University psychology researchers have found that although central vision allows our eyes to discern the details of a scene, our peripheral vision is most important for telling us...
News - 8 Apr 2013
A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will...
News - 14 Mar 2008
The U.S. legal system has long assumed that all testimony is not equally credible, that some witnesses are more reliable than others.
News - 22 Sep 2010
The American Dental Association (ADA) is extending invitations to those concerned about the oral health of vulnerable older adults and people with disabilities to attend a national conference and help...
News - 25 Jun 2010
Gastrointestinal stromal tumors are the most common mesenchymal tumors of the digestive tract. However, the duodenal location is less common. Nowadays, surgery is still the only curative approach for...